Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Ferraro

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|July 5, 2018
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosisDoriana Landi, Paolo Ragonese, Luca Prosperini, et al.
Journal of Neurology|September 28, 2018
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world studyLuca Prosperini, Pietro Annovazzi, Laura Boffa, et al.
Neurology|June 8, 2018
Fingolimod vs dimethyl fumarate in multiple sclerosis: A real-world propensity score-matched studyLuca Prosperini, Matteo Lucchini, Shalom Haggiag, et al.
CNS Drugs|July 20, 2018
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World StudyMassimiliano Mirabella, Luca Prosperini, Matteo Lucchini, et al.
British Journal of Pharmacology|November 16, 2021
Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1<sup>G93A</sup> miceSilvia Scaricamazza, Illari Salvatori, Susanna Amadio, et al.
Journal of Clinical Medicine|March 29, 2023
Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and DepressionCristiano Scandurra, Laura Rosa, Antonio Carotenuto, et al.
Therapeutic Advances in Neurological Disorders|December 31, 2025
Real-world experience with cladribine tablets in people with multiple sclerosis: effectiveness data from a multicenter Italian studyMatteo Lucchini, Giovanna Borriello, Shalom Haggiag, et al.
Journal of Neurology|November 14, 2019
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison studyLuca Prosperini, Antonio Cortese, Matteo Lucchini, et al.
Neurology and Therapy|September 19, 2025
Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of FrailtyGina Ferrazzano, Roberta Fantozzi, Shalom Haggiag, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 16, 2022
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS RegisterPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Journal of Neurology, Neurosurgery, and Psychiatry|July 5, 2018
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosisDoriana Landi, Paolo Ragonese, Luca Prosperini, et al.
Journal of Neurology|September 28, 2018
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world studyLuca Prosperini, Pietro Annovazzi, Laura Boffa, et al.
Neurology|June 8, 2018
Fingolimod vs dimethyl fumarate in multiple sclerosis: A real-world propensity score-matched studyLuca Prosperini, Matteo Lucchini, Shalom Haggiag, et al.
CNS Drugs|July 20, 2018
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World StudyMassimiliano Mirabella, Luca Prosperini, Matteo Lucchini, et al.
British Journal of Pharmacology|November 16, 2021
Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1<sup>G93A</sup> miceSilvia Scaricamazza, Illari Salvatori, Susanna Amadio, et al.
Journal of Clinical Medicine|March 29, 2023
Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and DepressionCristiano Scandurra, Laura Rosa, Antonio Carotenuto, et al.
Therapeutic Advances in Neurological Disorders|December 31, 2025
Real-world experience with cladribine tablets in people with multiple sclerosis: effectiveness data from a multicenter Italian studyMatteo Lucchini, Giovanna Borriello, Shalom Haggiag, et al.
Journal of Neurology|November 14, 2019
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison studyLuca Prosperini, Antonio Cortese, Matteo Lucchini, et al.
Neurology and Therapy|September 19, 2025
Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of FrailtyGina Ferrazzano, Roberta Fantozzi, Shalom Haggiag, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 16, 2022
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS RegisterPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.
Pageof 9